Collegium Pharmaceutical (STU:354) E10: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:354 Collegium Pharmaceutical Inc STU:354
69 GF Score
Price €19.80
GF Value €41.34
! 4 Warning Signs
View Full Analysis

What is Collegium Pharmaceutical E10?

Collegium Pharmaceutical STU:354 +2.06% 69 E10 is € as of Jun. 2026. GuruFocus rates STU:354 with a GF Score™ of 69/100 and a GF Value™ of €41.34. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Collegium Pharmaceutical's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.399. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-21), Collegium Pharmaceutical's current stock price is €19.80. Collegium Pharmaceutical's E10 for the quarter that ended in Jun. 2026 was . Collegium Pharmaceutical's Shiller PE Ratio of today is .


Collegium Pharmaceutical  (STU:354) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Collegium Pharmaceutical E10 Related Terms


Collegium Pharmaceutical E10 Historical Data

* Premium members only.

The historical data trend for Collegium Pharmaceutical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Collegium Pharmaceutical E10 Chart

Collegium Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Collegium Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:354 vs AMPH, IRWD, TLRY: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Collegium Pharmaceutical Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Collegium Pharmaceutical's Shiller PE Ratio falls into.


STU:354
69GF Score
Collegium Pharmaceutical Inc STU:354
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Collegium Pharmaceutical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Collegium Pharmaceutical's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.3988/333.9520*333.9520
=-0.399

Current CPI (Jun. 2026) = 333.9520.

Collegium Pharmaceutical Quarterly Data

per share eps CPI Adj_EPS
201609 -1.013 241.428 -1.401
201612 -0.943 241.432 -1.305
201703 -0.741 243.801 -1.015
201706 -0.654 244.955 -0.892
201709 -0.383 246.819 -0.519
201712 -0.459 246.524 -0.621
201803 -0.464 249.554 -0.621
201806 -0.336 251.989 -0.445
201809 -0.430 252.439 -0.569
201812 0.236 251.233 0.313
201903 -0.256 254.202 -0.337
201906 -0.126 256.143 -0.164
201909 -0.164 256.759 -0.213
201912 -0.059 256.974 -0.077
202003 0.012 258.115 0.015
202006 0.209 257.797 0.270
202009 0.276 260.280 0.353
202012 0.165 260.474 0.211
202103 0.339 264.877 0.428
202106 1.465 271.696 1.800
202109 0.188 274.310 0.229
202112 -0.642 278.802 -0.769
202203 -0.346 287.504 -0.402
202206 -0.143 296.311 -0.162
202209 0.013 296.808 0.015
202212 -0.210 296.797 -0.237
202303 -0.473 301.836 -0.524
202306 0.315 305.109 0.345
202309 0.487 307.789 0.528
202312 0.763 306.746 0.830
202403 0.652 312.332 0.697
202406 0.485 314.175 0.515
202409 0.244 315.301 0.258
202412 0.328 315.605 0.347
202503 0.070 319.799 0.073
202506 0.304 322.561 0.315
202509 0.718 324.800 0.738
202512 0.396 324.054 0.408
202603 0.341 330.213 0.345
202606 -0.399 333.952 -0.399

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of € mean?
Collegium Pharmaceutical (STU:354) has a E10 of € as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Collegium Pharmaceutical and its competitors.
Is Collegium Pharmaceutical's E10 too high?
Collegium Pharmaceutical's current E10 is €. Overall, Collegium Pharmaceutical has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Collegium Pharmaceutical's E10 compare to AMPH and IRWD?
Collegium Pharmaceutical's E10 of € can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Collegium Pharmaceutical and its competitors. Collegium Pharmaceutical's current E10 is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Collegium Pharmaceutical stock overvalued right now?
Collegium Pharmaceutical (STU:354) has a current E10 of €. The stock's GF Value™ is €41.34, compared to a current price of €19.80 — trading 52.1% below its estimated fair value. The current E10 is €. Collegium Pharmaceutical's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Collegium Pharmaceutical (STU:354), the current E10 is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Collegium Pharmaceutical (STU:354) Overvalued in 2026?

Based on GuruFocus' analysis, Collegium Pharmaceutical stock appears to be undervalued. The current stock price of €19.80 is trading 52.1% below its estimated GF Value™ of €41.34.

Key valuation signals for STU:354:

  • E10:
  • GF Value™: €41.34 vs. price of €19.80 (52.1% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the STU:354 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Collegium Pharmaceutical Business Description

Other Exchanges COLL:USA
Address 100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
69GF Score

Get the complete analysis for STU:354

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.80
Price
€41.34
GF Value